These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6351734)

  • 1. Polyoxin D inhibits growth of zoopathogenic fungi.
    Becker JM; Covert NL; Shenbagamurthi P; Steinfeld AS; Naider F
    Antimicrob Agents Chemother; 1983 Jun; 23(6):926-9. PubMed ID: 6351734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyoxin D inhibits colloidal gold-wheat germ agglutinin labelling of chitin in dimorphic forms of Candida albicans.
    Hilenski LL; Naider F; Becker JM
    J Gen Microbiol; 1986 Jun; 132(6):1441-51. PubMed ID: 3543207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of Candida albicans to epithelial cells effect of polyoxin D.
    Gottlieb S; Altboum Z; Savage DC; Segal E
    Mycopathologia; 1991 Sep; 115(3):197-205. PubMed ID: 1749403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; JabloĊ„ska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of anticandidal agents: synthesis and biological properties of analogues of polyoxin L.
    Shenbagamurthi P; Smith HA; Becker JM; Steinfeld A; Naider F
    J Med Chem; 1983 Oct; 26(10):1518-22. PubMed ID: 6352943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Candida activity of polyoxin: example of peptide transport in yeasts.
    Mehta RJ; Kingsbury WD; Valenta J; Actor P
    Antimicrob Agents Chemother; 1984 Mar; 25(3):373-4. PubMed ID: 6372683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
    Boonchird C; Flegel TW
    Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
    Hoeprich PD; Merry JM
    J Clin Microbiol; 1986 Aug; 24(2):269-71. PubMed ID: 3528213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of tripeptidyl polyoxins as antifungal agents.
    Naider F; Shenbagamurthi P; Steinfeld AS; Smith HA; Boney C; Becker JM
    Antimicrob Agents Chemother; 1983 Nov; 24(5):787-96. PubMed ID: 6362556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cerulenin and sodium butyrate on chitin synthesis in Candida albicans.
    Braun PC; Hector RF; Kamark ME; Hart JT; Cihlar RL
    Can J Microbiol; 1987 Jun; 33(6):546-50. PubMed ID: 2957042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticandidal properties of polyoxin L analogues containing alpha-amino fatty acids.
    Khare RK; Becker JM; Naider FR
    J Med Chem; 1988 Mar; 31(3):650-6. PubMed ID: 3279209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mode of action of polyoxins. VI. Effect of polyoxin B on chitin synthesis in polyoxin-sensitive and resistant strains of Alternaria kikuchiana.
    Hori M; Eguchi J; Kakiki K; Misato T
    J Antibiot (Tokyo); 1974 Apr; 27(4):260-6. PubMed ID: 4854490
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new polyoxin derivatives and their activity against chitin synthase from Candida albicans.
    Emmer G; Ryder NS; Grassberger MA
    J Med Chem; 1985 Mar; 28(3):278-81. PubMed ID: 3156247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.